As of 2024-09-19, the Relative Valuation of Marinus Pharmaceuticals Inc (MRNS) is (17.27) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.51 USD, the upside of Marinus Pharmaceuticals Inc based on Relative Valuation is -1243.9%.
The range of the Relative Valuation is (0.27) - (28.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 10.5x | 5.3x |
| Forward P/E multiples | 0.0x - 14.9x | 7.4x |
| Fair Price | (0.27) - (28.45) | (17.27) |
| Upside | -117.9% - -1984.0% | -1243.9% |
| Date | P/E |
| 2024-09-18 | -0.56 |
| 2024-09-17 | -0.57 |
| 2024-09-16 | -0.57 |
| 2024-09-13 | -0.55 |
| 2024-09-12 | -0.51 |
| 2024-09-11 | -0.51 |
| 2024-09-10 | -0.52 |
| 2024-09-09 | -0.51 |
| 2024-09-06 | -0.52 |
| 2024-09-05 | -0.51 |
| 2024-09-04 | -0.52 |
| 2024-09-03 | -0.53 |
| 2024-08-30 | -0.52 |
| 2024-08-29 | -0.52 |
| 2024-08-28 | -0.51 |
| 2024-08-27 | -0.54 |
| 2024-08-26 | -0.54 |
| 2024-08-23 | -0.48 |
| 2024-08-22 | -0.49 |
| 2024-08-21 | -0.51 |
| 2024-08-20 | -0.49 |
| 2024-08-19 | -0.49 |
| 2024-08-16 | -0.47 |
| 2024-08-15 | -0.45 |
| 2024-08-14 | -0.41 |
| 2024-08-13 | -0.44 |
| 2024-08-12 | -0.45 |
| 2024-08-09 | -0.45 |
| 2024-08-08 | -0.46 |
| 2024-08-07 | -0.43 |
| 2024-08-06 | -0.42 |
| 2024-08-05 | -0.41 |
| 2024-08-02 | -0.48 |
| 2024-08-01 | -0.52 |
| 2024-07-31 | -0.52 |
| 2024-07-30 | -0.51 |
| 2024-07-29 | -0.52 |
| 2024-07-26 | -0.53 |
| 2024-07-25 | -0.52 |
| 2024-07-24 | -0.52 |
| 2024-07-23 | -0.55 |
| 2024-07-22 | -0.55 |
| 2024-07-19 | -0.53 |
| 2024-07-18 | -0.51 |
| 2024-07-17 | -0.51 |
| 2024-07-16 | -0.54 |
| 2024-07-15 | -0.52 |
| 2024-07-12 | -0.51 |
| 2024-07-11 | -0.49 |
| 2024-07-10 | -0.45 |